Pairwise polymer blends for oral drug delivery

Journal of Pharmaceutical Sciences

Volumn 103, Issue 9, 2014, Pages 2871-2883

  Marks, Joyann A ^a   Wegiel, Lindsay A ^b   Taylor, Lynne S ^b   Edgar, Kevin J ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

amorphous solid dispersion; bioavailability; cellulose esters; dissolution; excipients; oral drug delivery; pairwise blends; polymeric biomaterials; PVP

Indexed keywords

BUTYRIC ACID DERIVATIVE; CARBOXYMETHYL CELLULOSE ACETATE BUTYRATE; CELLABURATE; CELLULOSE ACETATE ADIPATE PROPIONATE; DRUG CARRIER; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; POLYMER; POVIDONE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; DRUG; WATER;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; MISCIBILITY; ORAL DRUG ADMINISTRATION; BIOAVAILABILITY; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; MEDICINAL CHEMISTRY; PROCEDURES; SOLUBILITY;

BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PHARMACEUTICAL PREPARATIONS; POLYMERS; SOLUBILITY; WATER;

EID: 84906235733     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23991     Document Type: Article

References (77)

1. Klein S., 2009. Polysaccharides in oral drug delivery-Recent applications and future perspectives. Washington, DC: Polysaccharide Materials: Performance by Design, American Chemical Society, pp 13-30.
2. Bolhuis GK, Anthony AN,. 2006. Excipients for direct compaction-An update. Pharm Dev Technol 11 (1): 111-124.
3. Edgar KJ,. 2007. Cellulose esters in drug delivery. Cellulose 14 (1): 49-64.
4. Liu J, Chan SY, Ho PC,. 2002. Polymer-coated microparticles for the sustained release of nitrofurantoin. J Pharm Pharmacol 54 (9): 1205-1212.
5. Levine DS, Raisys VA, Ainardi V,. 1987. Coating of oral beclomethasone dipropionate capsules with cellulose acetate phthalate enhances delivery of topically active antiinflammatory drug to the terminal ileum. Gastroenterology 92 (4): 1037-1044.
6. Makhija SN, Vavia PR,. 2003. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semipermeable membrane. J Control Release 89 (1): 5-18.
7. Schultz P, Kleinebudde P,. 1997. A new multiparticulate delayed release system: Part I: Dissolution properties and release mechanism. J Control Release 47 (2): 181-189.
8. Sinha VR, Kumria R,. 2003. Coating polymers for colon specific drug delivery: A comparative in vitro evaluation. Acta Pharm 53 (1): 41-48.
9. Timpe C., 2010. Drug solubilization strategies: Applying nanoparticulate formulation and solid dispersion approaches in drug development. Am Pharm Rev 13 (1): 12.
10. Huang L-F, Tong W-QT,. 2004. Impact of solid state properties on developability assessment of drug candidates. Adv Drug Deliv Rev 56 (3): 321-334.
11. Janssens S, Van den Mooter G,. 2009. Review: Physical chemistry of solid dispersions. J Pharm Pharmacol 61 (12): 1571-1586.
12. Van den Mooter G,. 2012. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today Technol 9 (2): e79-e85.
13. Newman A, Knipp G, Zografi G,. 2012. Assessing the performance of amorphous solid dispersions. J Pharm Sci 101 (4): 1355-1377.
14. Trasi NS, Taylor LS,. 2012. Effect of polymers on nucleation and crystal growth of amorphous acetaminophen. CrystEngComm 14 (16): 5188-5197.
15. Ilevbare GA, Liu HY, Edgar KJ, Taylor LS,. 2012. Understanding polymer properties important for crystal growth inhibition-impact of chemically diverse polymers on solution crystal growth of ritonavir. Cryst Growth Des 12 (6): 3133-3143.
16. Ilevbare G, Liu H, Edgar KJ, Taylor L,. 2012. Inhibition of solution crystal growth of ritonavir by cellulose polymers-Factors influencing polymer effectiveness. CrystEngComm 14 (20): 6503-6514.
17. Alonzo DE, Gao Y, Zhou DL, Mo HP, Zhang GGZ, Taylor LS,. 2011. Dissolution and precipitation behavior of amorphous solid dispersions. J Pharm Sci 100 (8): 3316-3331.
18. Vasconcelos T, Sarmento B, Costa P,. 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 12 (23-24): 1068-1075.
19. Konno H, Handa T, Alonzo DE, Taylor LS,. 2008. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 70 (2): 493-499.
20. Ilevbare GA, Liu H, Edgar KJ, Taylor LS,. 2012. Effect of binary additive combinations on solution crystal growth of the poorly water-soluble drug, ritonavir. Cryst Growth Des 12 (12): 6050-6060.
21. Trasi NS, Taylor LS,. 2012. Effect of additives on crystal growth and nucleation of amorphous flutamide. Cryst Growth Des 12 (6): 3221-3230.
22. Ilevbare GA, Liu H, Edgar KJ, Taylor LS,. 2013. Impact of polymers on crystal growth rate of structurally diverse compounds from aqueous solution. Mol Pharm 10 (6): 2381-2393.
23. Liu H, Ilevbare GA, Cherniawski BP, Ritchie ET, Taylor LS, Edgar KJ,. 2014. Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions. Carbohydr Polym 100: 116-125.
24. Curatolo W, Nightingale JA, Herbig SM,. 2009. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res 26 (6): 1419-1431.
25. Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JAS,. 2008. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm 5 (6): 1003-1019.
26. Posey-Dowty J, Watterson T, Wilson A, Edgar K, Shelton M, Lingerfelt L,. 2007. Zero-order release formulations using a novel cellulose ester. Cellulose 14 (1): 73-83.
27. Shelton MC, Posey-Dowty JD, Lingerfelt L, Kirk SK, Klein S, Edgar KJ,. 2009. Enhanced dissolution of poorly soluble drugs from solid dispersions in carboxymethylcellulose acetate butyrate matrices. Washington, D.C.: Polysaccharide materials: Performance by design. American Chemical Society, pp 93-113.
28. Pereira JM, Mejia-Ariza R, Ilevbare GA, McGettigan HE, Sriranganathan N, Taylor LS, Davis RM, Edgar KJ,. 2013. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions. Mol Pharm 10 (12): 4640-4653.
29. Pradip, Maltesh C, Somasundaran P, Kulkarni RA, Gundiah S,. 1991. Polymer-polymer complexation in dilute aqueous solutions: Poly(acrylic acid)-poly(ethylene oxide) and poly(acrylic acid)-poly(vinylpyrrolidone). Langmuir 7 (10): 2108-2111.
30. Lyu SP, Sparer R, Hobot C, Dang K,. 2005. Adjusting drug diffusivity using miscible polymer blends. J Control Release 102 (3): 679-687.
31. Goddeeris C, Willems T, Houthoofd K, Martens JA, Van den Mooter G,. 2008. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. Eur J Pharm Biopharm 70 (3): 861-868.
32. Goddeeris C, Willems T, Van den Mooter G,. 2008. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Eur J Pharm Sci 34 (4-5): 293-302.
33. Janssens S, Denivelle S, Rombaut P, Van den Mooter G,. 2008. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends. Eur J Pharm Sci 35 (3): 203-210.
34. Janssens S, de Armas HN, Roberts CJ, Van den Mooter G,. 2008. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5. J Pharm Sci 97 (6): 2110-2120.
35. Coleman MM, Painter PC, Graf JF,. 1991. Specific interactions and the miscibility of polymer blends: Practical guides for predicting and designing miscible polymer mixtures. Boca Raton, FL:CRC Press.
36. Espi E, Fernandez-Berridi MJ, Iruin JJ,. 1994. An extension of the Painter-Coleman miscibility guide to ternary polymer blends. Polym Eng Sci 34 (17): 1314-1318.
37. Painter PC, Park Y, Coleman MM,. 1988. Hydrogen bonding in polymer blends. 2. Theory. Macromolecules 21 (1): 66-72.
38. Painter PC, Park Y, Coleman MM,. 1989. Thermodynamics of hydrogen bonding in polymer blends. 1. The application of association models. Macromolecules 22 (2): 570-579.
39. Masson JF, Manley RSJ,. 1991. Miscible blends of cellulose and poly (vinylpyrrolidone). Macromolecules 24 (25): 6670-6679.
40. Williams RO, Williams RO, Watts AAB, Miller DA,. 2012. Formulating poorly water soluble drugs. New York: Springer.
41. Sharma A, Jain C,. 2011. Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. Int J Drug Del 3 (2): 149-170.
42. Baird JA, Taylor LS,. 2012. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev 64 (5): 396-421.
43. Li B, Konecke S, Harich K, Wegiel L, Taylor LS, Edgar KJ,. 2013. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability. Carbohydr Polym 92 (2): 2033-2040.
44. Bettinetti G, Gazzaniga A, Mura P, Giordano F, Setti M,. 1992. Thermal-behavior and dissolution properties of naproxen in combinations with chemically modified beta-cyclodextrins. Drug Dev Ind Pharm 18 (1): 39-53.
45. Ceschel GC, Maffei P, Borgia SL, Ronchi C,. 2001. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv 8 (3): 161-171.
46. Durig T, Fassihi AR,. 1993. Identification of stabilizing and destabilizing effects of excipient-drug interactions in solid dosage form design. Int J Pharm 97 (1-3): 161-170.
47. Shmeis RA, Wang Z, Krill SL,. 2004. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part I: A comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry. Pharm Res 21 (11): 2025-2030.
48. Jorda R, Wilkes GL,. 1988. A novel use of physical aging to distinguish immiscibility in polymer blends. Polym Bull 20 (5): 479-485.
49. Pham TN, Watson SA, Edwards AJ, Chavda M, Clawson JS, Strohmeier M, Vogt FG,. 2010. Analysis of amorphous solid dispersions using 2D solid-state NMR and 1H T1 relaxation measurements. Mol Pharm 7 (5): 1667-1691.
50. Aso Y, Yoshioka S, Miyazaki T, Kawanishi T, Tanaka K, Kitamura S, Takakura A, Hayashi T, Muranushi N,. 2007. Miscibility of nifedipine and hydrophilic polymers as measured by 1H-NMR spin-lattice relaxation. Chem Pharm Bull (Tokyo) 55 (8): 1227-1231.
51. Aso Y, Yoshioka S, Zhang J, Zografi G,. 2002. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by 13C-NMR relaxation time. Chem Pharm Bull (Tokyo) 50 (6): 822-826.
52. Kar N, Liu H, Edgar KJ,. 2011. Synthesis of cellulose adipate derivatives. Biomacromolecules 12 (4): 1106-1115.
53. Fedors RF., 1974. A method for estimating both the solubility parameters and molar volumes of liquids. Polym Eng Sci 14 (2): 147-154.
54. Wise DL., 2000. Handbook of pharmaceutical controlled release technology. Boca Raton, FL:CRC Press.
55. Babcock W, Friesen D, Lyon D, Miller W, Smithey D,. 2006. Patent Application WO2006082518.
56. Ethers MC,. 1997. Technical handbook. Midland, Michigan: Dow Chemical Company.
57. Ilevbare GA, Liu H, Edgar KJ, Taylor LS,. 2013. Maintaining supersaturation in aqueous drug solutions: Impact of different polymers on induction times. Cryst Growth Des 13 (2): 740-751.
58. Sarisuta N, Lawanprasert P, Puttipipatkhachorn S, Srikummoon K,. 2006. The influence of drug-excipient and drug-polymer interactions on butt adhesive strength of ranitidine hydrochloride film-coated tablets. Drug Dev Ind Pharm 32 (4): 463-471.
59. Cui F, Wang Y, Wang J, Feng L, Ning K,. 2007. Preparation of redispersible dry emulsion using Eudragit E100 as both solid carrier and unique emulsifier. Colloids Surf Physicochem Eng Aspects 307 (1): 137-141.
60. Quinteros DA, Rigo VR, Kairuz AFJ, Olivera ME, Manzo RH, Allemandi DA,. 2008. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 33 (1): 72-79.
61. Bharate SS, Bharate SB, Bajaj AN,. 2010. Incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: A comprehensive review. J Excip Food Chem 1 (3): 3-26.
62. Dokou E, Brodeur GG, Tauber M, Sanghvi T, Knezic D, Pesha Y, Johnston MM, Hurrey M, Arekar SG, Penumatcha R,. 2013. Patent Application US20130195797 A1.
63. Shah N, Iyer RM, Mair H-J, Choi DS, Tian H, Diodone R, Fähnrich K, Pabst-Ravot A, Tang K, Scheubel E, Grippo JF, Moreira SA, Go Z, Mouskountakis J, Louie T, Ibrahim PN, Sandhu H, Rubia L, Chokshi H, Singhal D, Malick W,. 2013. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process. J Pharm Sci 102 (3): 967-981.
64. Posey-Dowty J, Watterson T, Edgar K, Kirk S, Welty M, Yuan J, Shelton M, Lingerfelt L, Wilson A,. 2007. Patent Application WO2007056125.
65. Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS,. 2012. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers. J Pharm Sci 102 (1): 171-184.
66. Laurence C, Brameld KA, Graton J, Le Questel J-Y, Renault E,. 2009. The p K BHX database: toward a better understanding of hydrogen-bond basicity for medicinal chemists. J Med Chem 52 (14): 4073-4086.
67. Fox TG., 1956. Influence of diluent and of copolymer composition on the glass temperature of a polymer system. Bull Am Phys Soc 1 (123): 22060-26218.
68. Nyamweya N, Hoag SW,. 2000. Assessment of polymer-polymer interactions in blends of HPMC and film forming polymers by modulated temperature differential scanning calorimetry. Pharm Res 17 (5): 625-631.
69. Chokshi RJ, Shah NH, Sandhu HK, Malick AW, Zia H,. 2008. Stabilization of low glass transition temperature indomethacin formulations: Impact of polymer-type and its concentration. J Pharm Sci 97 (6): 2286-2298.
70. Miller WK, Lyon DK, Friesen DT, Caldwell WB, Vodak DT, Dobry DE,. 2010. Patent Application WO2011159626.
71. Karavas E, Georgarakis E, Bikiaris D,. 2006. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm 64 (1): 115-126.
72. Yang Z, Nollenberger K, Albers J, Craig D, Qi S,. 2013. Microstructure of an immiscible polymer blend and its stabilization effect on amorphous solid dispersions. Mol Pharm 10 (7): 2767-2780.
73. McPhillips H, Craig DQM, Royall PG, Hill VL,. 1999. Characterisation of the glass transition of HPMC using modulated temperature differential scanning calorimetry. Int J Pharm 180 (1): 83-90.
74. Bureau G, Longpré F, Martinoli MG,. 2008. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 86 (2): 403-410.
75. Igura K, Ohta T, Kuroda Y, Kaji K,. 2001. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171 (1): 11-16.
76. Li B, Wegiel LA, Taylor LS, Edgar KJ,. 2013. Stability and solution concentration enhancement of resveratrol by solid dispersion in cellulose derivative matrices. Cellulose 20 (3): 1249-1260.
77. Kashdan DS., 1989. Patent US 4,795,641.